Lv15
78 积分 2023-01-17 加入
Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions
1天前
待确认
Dual-target EZH2 inhibitor: latest advances in medicinal chemistry
2天前
已完结
Recent advances in EZH2-based dual inhibitors in the treatment of cancers
2天前
已完结
LSD1 in drug discovery: From biological function to clinical application
2天前
已完结
The application of PROTACs in immune-inflammation diseases
10天前
已完结
Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development
17天前
已完结
MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment
24天前
已完结
Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic Payloads
24天前
已完结
Structural and Physicochemical Features of Oral PROTACs
29天前
已完结
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
1个月前
已完结
皖公网安备34019202002308
